tradingkey.logo
tradingkey.logo

Orthofix Medical Inc

OFIX
11.322USD
-0.468-3.97%
Market hours ETQuotes delayed by 15 min
212.04MMarket Cap
LossP/E TTM

Orthofix Medical Inc

11.322
-0.468-3.97%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Orthofix Medical Inc

Currency: USD Updated: 2026-03-27

Key Insights

Orthofix Medical Inc's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 47 out of 208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 17.25.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Orthofix Medical Inc's Score

Industry at a Glance

Industry Ranking
47 / 208
Overall Ranking
141 / 4542
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Orthofix Medical Inc Highlights

StrengthsRisks
Orthofix Medical Inc. is a global medical technology company. The Company offers a portfolio of spinal hardware, bone growth therapies, specialized orthopedic solutions, biologics and enabling technologies, including the 7D FLASH navigation system. The Company’s Global Spine segment offers two primary product categories: bone growth therapies and spinal implants, biologics, and enabling technologies. The segment provides implantable medical devices, biologics, enabling technologies, and other regenerative solutions which aim to restore the quality of life of patients suffering from diseases and traumas of the spine. It offers a variety of treatment solutions that incorporate multiple treatment modalities, such as mechanical, biological, and electromagnetic modes. Its Global Orthopedics segment offers products and solutions for limb deformity correction and complex limb reconstruction with a focus on use in trauma, adult and pediatric limb reconstruction, and foot and ankle procedures.
Fairly Valued
The company’s latest PE is -4.94, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 35.98M shares, decreasing 10.73% quarter-over-quarter.
Held by PRFDX
Star Investor PRFDX holds 21.77K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.25.

Analyst Rating

Based on 6 analysts
Buy
Current Rating
17.250
Target Price
+46.31%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-03-27

The current financial score of Orthofix Medical Inc is 6.24, ranking 159 out of 208 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 219.91M, representing a year-over-year increase of 1.97%, while its net profit experienced a year-over-year increase of 92.38%.

Score

Industry at a Glance

Previous score
6.24
Change
0

Financials

6.96

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

2.46

Operational Efficiency

7.57

Growth Potential

7.09

Shareholder Returns

7.15

Orthofix Medical Inc's Company Valuation

Currency: USD Updated: 2026-03-27

The current valuation score of Orthofix Medical Inc is 7.76, ranking 58 out of 208 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -4.94, which is -49.48% below the recent high of -2.50 and -367.84% above the recent low of -23.11.

Score

Industry at a Glance

Previous score
7.76
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 47/208
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-03-27

The current earnings forecast score of Orthofix Medical Inc is 8.00, ranking 61 out of 208 in the Healthcare Equipment & Supplies industry. The average price target is 23.00, with a high of 27.20 and a low of 18.00.

Score

Industry at a Glance

Previous score
8.00
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 6 analysts
Buy
Current Rating
17.250
Target Price
+46.31%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

115
Total
6
Median
9
Average
Company name
Ratings
Analysts
Orthofix Medical Inc
OFIX
6
Medtronic PLC
MDT
34
Stryker Corp
SYK
33
Abbott Laboratories
ABT
31
Dexcom Inc
DXCM
31
Zimmer Biomet Holdings Inc
ZBH
31
1
2
3
...
23

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-03-27

The current price momentum score of Orthofix Medical Inc is 6.37, ranking 137 out of 208 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 12.99 and the support level at 10.71, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
6.64
Change
-0.27

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(4)
Neutral(2)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
0.012
Neutral
RSI(14)
33.490
Neutral
STOCH(KDJ)(9,3,3)
26.560
Sell
ATR(14)
0.433
Low Volatility
CCI(14)
-150.089
Sell
Williams %R
93.496
Oversold
TRIX(12,20)
-0.520
Sell
StochRSI(14)
0.000
Sell
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
11.762
Sell
MA10
11.792
Sell
MA20
12.160
Sell
MA50
12.895
Sell
MA100
14.131
Sell
MA200
13.707
Sell

Institutional Confidence

Currency: USD Updated: 2026-03-27

The current institutional shareholding score of Orthofix Medical Inc is 10.00, ranking 1 out of 208 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 90.87%, representing a quarter-over-quarter decrease of 1.23%. The largest institutional shareholder is The Vanguard, holding a total of 2.29M shares, representing 5.69% of shares outstanding, with 2.70% increase in holdings.

Score

Industry at a Glance

Previous score
10.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
Engine Capital Management, LP
4.25M
+0.03%
Juniper Investment Company, LLC
3.24M
+13.92%
Rubric Capital Management LP
3.72M
--
Paradigm Capital Management, Inc.
3.34M
+0.12%
BlackRock Institutional Trust Company, N.A.
2.83M
-1.29%
Armistice Capital LLC
2.24M
-24.92%
The Vanguard Group, Inc.
Star Investors
2.26M
-2.00%
Millennium Management LLC
1.48M
+86.59%
Philosophy Capital Management LLC
883.61K
+4.53%
Dimensional Fund Advisors, L.P.
1.14M
+6.39%
1
2

Risk Assessment

Currency: USD Updated: 2026-03-27

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Orthofix Medical Inc is 6.83, ranking 52 out of 208 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.81. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.

Score

Industry at a Glance

Previous score
6.83
Change
0
Beta vs S&P 500 index
0.82
VaR
+4.01%
240-Day Maximum Drawdown
+29.14%
240-Day Volatility
+48.08%

Return

Best Daily Return
60 days
+3.30%
120 days
+6.79%
5 years
+19.53%
Worst Daily Return
60 days
-6.18%
120 days
-7.41%
5 years
-30.17%
Sharpe Ratio
60 days
-3.76
120 days
-1.15
5 years
-0.39

Risk Assessment

Maximum Drawdown
240 days
+29.14%
3 years
+54.63%
5 years
+77.39%
Return-to-Drawdown Ratio
240 days
-0.54
3 years
-0.22
5 years
-0.19
Skewness
240 days
+0.45
3 years
-0.84
5 years
-0.76

Volatility

Realised Volatility
240 days
+48.08%
5 years
+49.27%
Standardised True Range
240 days
+4.46%
5 years
+6.72%
Downside Risk-Adjusted Return
120 days
-173.68%
240 days
-173.68%
Maximum Daily Upside Volatility
60 days
+27.40%
Maximum Daily Downside Volatility
60 days
+29.69%

Liquidity

Average Turnover Rate
60 days
+1.10%
120 days
+1.00%
5 years
--
Turnover Deviation
20 days
+24.97%
60 days
+1.87%
120 days
-7.38%

Peer Comparison

Healthcare Equipment & Supplies
Orthofix Medical Inc
Orthofix Medical Inc
OFIX
7.28 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc
TMO
8.39 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Bioventus Inc
Bioventus Inc
BVS
8.28 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Anika Therapeutics Inc
Anika Therapeutics Inc
ANIK
8.13 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lantheus Holdings Inc
Lantheus Holdings Inc
LNTH
8.07 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Edwards Lifesciences Corp
Edwards Lifesciences Corp
EW
8.05 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI